Cytokinetics sec filings
WebFeb 24, 2024 · Cytokinetics Inc CIK: 1061983 Ticker: CYTK GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies WebApr 11, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as …
Cytokinetics sec filings
Did you know?
WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in … WebUnder the Securities Exchange Act of 1934 (AMENDMENT NO. 1) CYTOKINETICS, INCORPORATED (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER …
WebPipeline - Cytokinetics A pipeline powered by passion pipeline Research Pre-Clinical Phase 1 Phase 2 Phase 3 CARDIAC MUSCLE Omecamtiv Mecarbil (Heart Failure) Aficamten (oHCM) Aficamten (nHCM) CK-136 (Heart Failure, other) CK-586 SKELETAL MUSCLE Reldesemtiv (ALS) Additional Skeletal Muscle Activators Other Muscle Biology … WebApr 12, 2024 · The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, CEO Robert I. Blum sold 12,500 shares of the stock in a transaction that ...
WebThis will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of Cytokinetics, Incorporated, a Delaware corporation, will be filed on behalf of … WebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com.
WebFeb 17, 2024 · Cytokinetics Inc CIK: 1061983 Ticker: CYTK GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies
WebApr 4, 2024 · Pinnacle Associates Ltd. owned approximately 0.30% of Cytokinetics worth $11,556,000 as of its most recent SEC filing. Want Diversified Upside in Biotechnology? … imece2021 toshibaWebApr 12, 2024 · Oregon Public Employees Retirement Fund lifted its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 1.0% in the 4th quarter, … imec construction corpWebFeb 22, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. … imecc trainingWebNov 4, 2024 · SEC Filings Cytokinetics Inc (CYTK) 10-Q Quarterly Report Fri Nov 04 2024 SEC Filings CYTK Valuations Intrinsic Value Financial Stability Financial Ratios Insider … list of nba players heights rozierWebJan 9, 2024 · Filings & Forms All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. Anyone can access and download this information for free. Here you'll find links to a complete list of filings available through EDGAR and instructions for searching the … imec covid testWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. list of nba hall of fame membersWebJul 1, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in … list of nba players by score